A Pilot Study of Chronochemotherapy for Nasopharyngeal Carcinoma

References

1. 1. Levi F,
   2. Zidani R,
   3. Misset JL

   . Randomised multi-centre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colonectal cancer. Lancet. 1997;350:681.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Giacchetti S,
   2. Bjamason G,
   3. Garufi C, et al

   . Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as' first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol. 2006;24:3562–3569.

   OpenUrlAbstract/FREE Full Text
3. ↵
   1. Kobayashi M,
   2. Wood PA,
   3. Hrushesky WJ

   . Circadian chemotherapy for gynecologyical and genitourinary cancer. Chronobiol Int. 2002;19:237–251.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Hecquet B,
   2. Meynadier J,
   3. Bonneterre J, et al

   . Time dependency in plasmatic protein binding of cisplatin. Cancer Treat Rep. 1985;69:79–83.

   OpenUrlPubMed
5. ↵
   1. Sun J,
   2. Xian LJ,
   3. Cao QY, et al

   . Circadina rhythms of DNA syntheses and apoptosis correlated gene expression in bone marrow cells of nude mice bearing nasopharyngeal carcinoma. Cancer. 2002;21:833–837 (Chinese).

   OpenUrl
6. ↵
   1. Sun J,
   2. Xian LJ,
   3. Cao QY, et al

   . Circadian rhythms of DNA syntheses in human nasopharyngeal carcinoma cells transplanted in nude mice. Cancer. 2001;20:128–130 (Chinese).

   OpenUrl
7. ↵
   1. Yang XL,
   2. Liu J

   . Therapeutic effect of chrono-chemotherapy (DDP and 5-FU) combined with radiotherapy for advanced or recurrent NPC. Chin J Clin Oncol. 2001;28:42–45 (Chinese).

   OpenUrl
8. ↵
   1. Qu YQ,
   2. Dong LH,
   3. Li BY, et al

   . The impact of Lvyangkui on T cell subset in advanced stage non small cell lung cancer. Chin J Clin Oncol. 2001;28:155–157 (Chinese).

   OpenUrl
9. ↵
   1. Hu JW,
   2. Wang XL

   . Dynamic observation of T cell subsets and soluble interleukint2 receptor in the chemotherapy of patients with lung cancer. Chin J Clin Oncol. 1995;22: 768–769 (Chinese).

   OpenUrl
10. ↵
    1. Zhou TH,
    2. Zen ZY,
    3. Wu HR

    . The impact of neoadjuvant chemotherapy on T cell subset in head and neck squamous cell carcinoma. Chin J ENT, 1996;31:189 (Chinese).

    OpenUrl
11. ↵
    1. Li M,
    2. Yu XJ,
    3. Wang XU, et al

    . The influence of chemotherapy on cell immunological function in advance stage lung cancer. Shandong Med J. 2000;40:18–19 (Chinese).

    OpenUrl
12. ↵
    1. Price T,
    2. Karapetis C, Cheralier, et al

    . Chronomodulated chemotherapy in advanced colorectal carcinoma. J Clin Oncol. 2002;20:3937–3939.

    OpenUrlFREE Full Text